Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line: An in vitro study

Bone and Joint Journal

Volumn 95 B, Issue 11, 2013, Pages 1575-1580

  Salai, M ^a   Somjen, D ^a   Gigi, R ^a   Yakobson, O ^a   Katzburg, S ^a   Dolkart, O ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; METFORMIN; METOPROLOL; OMEPRAZOLE; ROSUVASTATIN;

BONE MINERALIZATION; BONE TISSUE; DNA SYNTHESIS; OSTEOBLAST; PRIORITY JOURNAL; REVIEW;

EID: 84888342566     PISSN: None     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.95B11.31158     Document Type: Review

References (34)

1. Fogh J, Fogh JM, Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 1977;59: 221-226.
2. Rodan SB, Imai Y, Thiede MA, et al. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res 1987;47: 4961-4966.
3. Hausser HJ, Brenner RE. Phenotypic instability of Saos-2 cells in long-term culture. Biochem Biophys Res Commun 2005;333: 216-222.
4. Lazzerini PE, Capperucci C, Spreafico A, et al. Rosuvastatin inhibits spontaneous and IL-1-induced interleukin-6 production from human cultured osteoblastic cells. Joint Bone Spine 2013;80: 195-200.
5. Mai QG, Zhang ZM, Xu S, et al. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem 2011;112: 2902-2909.
6. Lai KB, Sanderson JE, Yu CM. High dose norepinephrine-induced apoptosis in cultured rat cardiac fibroblast. Int J Cardiol 2009;136: 33-39.
7. Hodge JM, Wang Y, Berk M, et al. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol Psychiatry 2013;74: 32-39.
8. Sheraly AR, Lickorish D, Sarraf F, Davies JE. Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo. Curr Drug Deliv 2009;6: 192-198.
9. Somjen D, Kohen F, Lieberherr M, et al. Membranal effects of phytoestrogens and carboxy derivatives of phytoestrogens on human vascular and bone cells: new insights based on studies with carboxy-biochanin A. J Steroid Biochem Mol Biol 2005;93: 293-303.
10. Katzburg S, Lieberherr M, Ornoy A, et al. Isolation and hormonal responsiveness of primary cultures of human bone-derived cells: gender and age differences. Bone 1999;25: 667-673.
11. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004;109(Suppl):III39-III43.
12. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000;6: 1399-1402.
13. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286: 1946-1949.
14. Gutierrez GE, Zhang J, Jadhav S, Munoz SA, Mundy GR. Enhanced expression of BMP2/Smad pathway and SP7 by statins during fracture repair. Bone 2008;42:S17-110.
15. Tang QO, Tran GT, Gamie Z, et al. Statins: under investigation for increasing bone mineral density and augmenting fracture healing. Expert Opin Investig Drugs 2008;17: 1435-1463.
16. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001;280: 874-877.
17. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000;283: 3205-3210.
18. Cauley JA, Jackson R, Pettinger M, et al. Statin use and bone mineral density (BMD) in older women: The Women's Health Initiative Observational Study. J Bone Min Res 2000;15(Suppl):155.
19. LaCroix AZ, Cauley JA, Jackson R. Does statin use reduce risk of fracture in postmenopausal women?: results from the Women's Health Initiative Observational Study. J Bone Min Res 2000;15(Suppl):155.
20. van Staa TP, Wegman SLJ, de Vries F, Leufkens HGM, Cooper C. Use of statins and risk of fractures. J Bone Miner Res 2000;15(suppl):155.
21. Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA 1992;268: 3333-3337.
22. Kanazawa I. Usefulness of metformin in diabetes-related bone disease. Clin Calcium 2009;19:1319-1325 (in Japanese).
23. Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L. Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol 2006;536: 38-46.
24. Straand J, Rokstad KS. Elderly patients in general practice: diagnoses, drugs and inappropriate prescriptions: a report from the Møre & Romsdal Prescription Study. Fam Pract 1999;16: 380-388.
25. Reid IR. Effects of beta-blockers on fracture risk. J Musculoskelet Neuronal Interact 2008;8: 105-110.
26. Cherruau M, Facchinetti P, Baroukh B, Saffar JL. Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone 1999;25: 545-551.
27. Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 2002;58: 77-84.
28. Bonnet N, Laroche N, Vico L, et al. Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther 2006;318:1118- 1127.
29. Haney EM, Chan BK, Diem SJ, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 2007;167: 1246-1251.
30. Haney EM, Warden SJ, Bliziotes MM. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? Bone 2010;46: 13-17.
31. Graziani G, Como G, Badalamenti S, et al. Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrol Dial Transplant 1995;10: 1376-1380.
32. O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 2005;118: 778-781.
33. Histing T, Stenger D, Scheuer C, et al. Pantoprazole, a proton pump inhibitor, delays fracture healing in mice. Calcif Tissue Int 2012;90: 507-514.
34. Klein BY, Rojansky N, Ben-Yehuda A, et al. Cell death in cultured human Saos2 osteoblasts exposed to low-density lipoprotein. J Cell Biochem 2003;90: 42-58.